The present invention relates to a process for preparing biodegradable polyurea/polyurethane microcapsules, preferably perfume-containing polyurea/polyurethane microcapsules, which have improved biodegradability compared to prior art microcapsules. In addition, the present invention relates to biodegradable polyurea/polyurethane microcapsules comprising at least one lipophilic active ingredient obtainable by the process according to the invention. In another aspect, the invention described herein relates to the use of such microcapsules or microcapsule dispersions comprising the microcapsules according to the invention for the manufacture of household products, textile care products, detergents, fabric softeners, cleaning agents, scent boosters, scent lotions or scent enhancers, cosmetics, personal care products, agricultural products, pharmaceutical products or printing coatings for paper. Ultimately, the present invention relates to consumer products comprising such microcapsules or microcapsule dispersions.

A method for producing microcapsules with core material and shell material includes following steps: a) providing an aqueous two-phase system comprising at least one salt, which is at least partially not dissolved in this two-phase system and a core material, which is one phase of the two-phase system, and b) adding two solutions i) and ii) in the presence of at least one polymer soluble in solution i) and/or ii), wherein solution i) contains at least one salt of a cation of the salt from step a) and solution ii) contains at least one salt of an anion of the salt from step a). Microcapsules can be obtained or obtainable by the above method, and the microcapsules can be used in products and compositions.

A method for producing microcapsules with core material and shell material includes following steps: a) providing an aqueous two-phase system comprising at least one salt, which is at least partially not dissolved in this two-phase system and a core material, which is one phase of the two-phase system, and b) adding two solutions i) and ii) in the presence of at least one polymer soluble in solution i) and/or ii), wherein solution i) contains at least one salt of a cation of the salt from step a) and solution ii) contains at least one salt of an anion of the salt from step a). Microcapsules can be obtained or obtainable by the above method, and the microcapsules can be used in products and compositions.

Provided is a filling liquid (161) for filling a balloon (170) for a method for occluding a tubular organ, including a microcapsule (162) in which a balloon-dissolving substance that dissolves the balloon (170) is encapsulated, wherein the microcapsule is destroyable by an ultrasonic beam; and a liquid that is harmless in the tubular organ and does not dissolve the balloon. Further provided is a method for terminating a tubular organ occlusion including a step of applying an ultrasonic beam to a balloon (170) that is filled with the filling liquid (161) and occludes a tubular organ, thereby breaking the balloon (170) as a result.

A hybrid encapsulate formulation obtained by mixing a starch/fragrance emulsion with a core-shell capsule suspension is provided as is a method of using the formulation in a personal care product, a beauty care product, a fabric care product, a home care product, a personal hygiene product, an oral care product and a method for releasing an encapsulated fragrance by moisture, shear, or a combination thereof.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.

Particulate material comprising rough mesoporous hollow nanoparticles. The rough mesoporous hollow nanoparticles may comprise a mesoporous shell, the external surface of which has projections thereon, the projections having smaller sizes than the particle size. The particulate material may be used to deliver active agents, such as insecticides and pesticides. The active agents can enter into the hollow core of the particles and be protected from degradation by sunlight. The rough surface of the particles retains the particles on plant leaves or animal hair. Methods for forming the particles are also described. Carbon particles and methods for forming carbon particles are also described.

Particulate material comprising rough mesoporous hollow nanoparticles. The rough mesoporous hollow nanoparticles may comprise a mesoporous shell, the external surface of which has projections thereon, the projections having smaller sizes than the particle size. The particulate material may be used to deliver active agents, such as insecticides and pesticides. The active agents can enter into the hollow core of the particles and be protected from degradation by sunlight. The rough surface of the particles retains the particles on plant leaves or animal hair. Methods for forming the particles are also described. Carbon particles and methods for forming carbon particles are also described.

A double-chamber microcapsule includes a capsule core and a microcapsule wall encapsulating the capsule core, wherein the microcapsule wall is a thermo-sensitive polymer encapsulating the content of a second chamber; the capsule core is a pH responsive polymer encapsulating the content of a first chamber, the pH responsive polymer is obtained by polymerizing a pH responsive monomer and a cross-linking monomer; the content of the first chamber is different from the content of the second chamber, each is selected from a solid acid or a solid alkali.